C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2004
12/02/2004	WO2004103976A2 Method for synthesising heterocyclic compounds from thiourea derivatives
12/02/2004	WO2004103367A1 Benzothiazole derivatives and use thereof in the treatment of diseases relates to the adenosine a2a receptor
12/02/2004	WO2004103366A1 Heterocyclic compounds useful to treat hcv
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	US20040242933 Process for preparation of ethene derivatives
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242884 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242657 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease
12/02/2004	US20040242637 drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242602 Novel thiazolidine compounds as calcium sensing receptor modulators
12/02/2004	US20040242576 Urea substituted benzothiazoles
12/02/2004	US20040242560 Process for synthesizing heterocyclic compounds
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability
12/02/2004	US20040237214 Aniline, thiophene, furan, thiazole, triazole or pyrazole dye couplers; hair dyes with improved colorfastness, washfastness and photostability
12/02/2004	CA2526646A1 Method for synthesising heterocyclic compounds from thiourea derivatives
12/02/2004	CA2525501A1 Tetrahydroisoquinoline derivatives as ppar-.alpha. activators
12/02/2004	CA2525102A1 Benzothiazole derivatives and use thereof in the treatment of diseases relates to the adenosine a2a receptor
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480976A1 Thiazole derivatives as npy receptor antagonists
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004	EP1480944A2 Substituted aryl ketones
12/01/2004	EP1480642A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP1480641A1 Substituted thiazoles and oxazoles that modulate ppar activity
12/01/2004	EP1480640A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551875A M-aminophenol derivatives and coloring agents containing them
12/01/2004	CN1551871A Process for preparinga thiazole PPAR-ligand and polymorphs thereof
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177823C Pesticides
12/01/2004	CN1177586C Use of pramipexole as nerveprotective agent
12/01/2004	CN1177533C Composition for combating plant pests
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825345 Reacting 7-amino-3-vinylceph-3-em-4-carboxylic acid with 2-(2-amino-4-thiazolyl-2(aryl or alkyl)oxycarbonylmethyoxy-iminoacetylthio-)benzothiazole to obtain cefixime; salt formation with tert-octylamine; crystal structure
11/30/2004	US6825223 Anilide compounds and pharmaceutical compositions comprising them
11/30/2004	US6825222 Modulators of peroxisome proliferator activated receptors
11/30/2004	CA2108864C Improved process for the preparation of 2-methylthiazole-5-carboxylates
11/25/2004	WO2004101573A1 Synthesis of substituted heterocyclic compounds
11/25/2004	WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004	WO2004101505A1 Novel compounds for treatment of obesity
11/25/2004	WO2004100881A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004	WO2004089942A3 Benzimidazolidinone derivatives as muscarinic agents
11/25/2004	WO2004089356A3 Targeted bone marrow protection agents
11/25/2004	WO2004084842A3 Inhibitors of cathepsin s
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235918 Of high purity and yield by cyclization reaction of dimethyl N-cyanoiminodithiocarbonate ester with 2-aminoethanethiol or salt thereof in the presence of alkali metal hydroxide; use as chemical intermediate to drugs, agrochemicals
11/25/2004	US20040235917 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
11/25/2004	US20040235916 Thiazolyl amides and their use as antiviral drugs
11/25/2004	US20040235915 Benzothiazole derivatives
11/25/2004	US20040235914 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
11/25/2004	US20040235913 drug abuse; psychological disorders; antidepressants; sexual disorders; hypotensive agents; anxiolytic agernts; Alzheimer's disease; schizophrenia; Parkinson's disease; sleep disorders; reastless leg syndrome; irritable bowel syndrome
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235842 For therapy of Alzheimer's disease, depression
11/25/2004	US20040235837 Method for treating fibrotic diseases or other indications IE
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235666 Substituted imidates as pesticidal agents
11/25/2004	US20040231064 3-Aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
11/25/2004	CA2524706A1 Synthesis of substituted heterocyclic compounds
11/25/2004	CA2524470A1 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004	EP1478631A1 Therapeutic compounds
11/24/2004	EP1478630A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1259498B1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
11/24/2004	EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs
11/24/2004	CN1176915C Alkynyl phenyl heteroaromatic glucokinase activators
11/24/2004	CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/23/2004	US6821991 2-substituted thiazolidinones as β-3 adrenergic receptor agonists
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	CA2105503C Carboxanilides, their preparation and compositions containing them for controlling harmful fungi
11/18/2004	WO2004099175A2 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	WO2004099170A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099168A2 Substituted carboxylic acids
11/18/2004	WO2004099165A2 Heterocyclic compounds and hydro isomers thereof
11/18/2004	WO2004099146A1 Benzamide inhibitors of the p2x7 receptor
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004099127A1 Novel compounds as kinase inhibitors
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004098494A2 Compounds, compositions, and methods

1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 337